SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE. RMSR. 2025;3(1):522-531. Accessed August 6, 2025. https://medscireview.net/index.php/Journal/article/view/403